Cardiff Oncology
CRDF
CRDF
47 hedge funds and large institutions have $3.84M invested in Cardiff Oncology in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less funds holding
Funds holding: 48 → 47 (-1)
10% less capital invested
Capital invested by funds: $4.25M → $3.84M (-$416K)
Holders
47
Holding in Top 10
–
Calls
$2K
Puts
$1K
Top Buyers
| 1 | +$1.23M | |
| 2 | +$269K | |
| 3 | +$256K | |
| 4 |
EP
Elkhorn Partners
Omaha,
Nebraska
|
+$78.9K |
| 5 |
VF
Virtu Financial
New York
|
+$58K |
Top Sellers
| 1 | -$194K | |
| 2 | -$166K | |
| 3 | -$151K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$104K |
| 5 |
Morgan Stanley
New York
|
-$48.8K |